Skip to main content
SpringerLink
Log in

Drug and doctors' costs influence decisions of patients with HCV

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Mattingly TJ 2nd, et al. What Matters Most for Treatment Decisions in Hepatitis C: Effectiveness, Costs, and Altruism. The Patient - Patient-Centered Outcomes Research : 26 Jul 2019. Available from: URL: http://doi.org/10.1007/s40271-019-00378-7

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Drug and doctors' costs influence decisions of patients with HCV. PharmacoEcon Outcomes News 834, 16 (2019). https://doi.org/10.1007/s40274-019-6116-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-019-6116-y

Search

Navigation